Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells

Journal of Leukocyte Biology

Volumn 74, Issue 4, 2003, Pages 593-601

  Leone, Francesco ^a,b   Perissinotto, Eliana ^a   Cavalloni, Giuliana ^a   Fonsato, Valentina ^a   Bruno, Stefania ^a   Surrenti, Nadia ^a   Hong, Dengli ^a   Capaldi, Antonio ^a   Geuna, Massimo ^a   Piacibello, Wanda ^a   Aglietta, Massimo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

CD34+ progenitors; Differentiation; Hematopoiesis; Mature blood cells; Proliferation

Indexed keywords

CD14 ANTIGEN; CD15 ANTIGEN; CD34 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOPHORIN A; MESSENGER RNA;

ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; PROTO ONCOGENE; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; CELL DIVISION; CELLS, CULTURED; FETAL BLOOD; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEM; HUMANS; RECEPTOR, ERBB-2; RNA, MESSENGER;

EID: 9144228178     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0203068     Document Type: Article

References (28)

1. Coussens, L., Yang-Fenf, T. L., Liao, Y. C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230, 1132-1139.
2. King, C. R., Kraus, M. H., Aaronson, S. A. (1985) Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229, 974-976.
3. Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., Yamamoto, T. (1986) The product of the human c-erbB-2 gene: a 185-kilodalton glicoprotein with tyrosine kinase activity. Science 232, 1644-1646.
4. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) Studies of HER2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712.
5. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ulrich, A., McGuire, W. L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene. Science 235, 177-182.
6. Seshadri, R., Firgaira, F. A., Horsfall, D. J., McCaul, K., Setlur, V., Kitchen, P. (1993) Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. J. Clin. Oncol. 11, 1936-1942.
7. Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., Baselga, J., Norton, L. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344, 783-792.
8. Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., Shak, S., Stewart, S. J., Press, M. (2002) Efficacy and safety of Trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 20, 719-726.
9. Gazzaniga, P., Gandini, O., Giuliani, L., Magnanti, M., Gradilone, A., Silvestri, I., Gianni, W., Gallucci, M., Frati, L., Agliano, A. M. (2001) Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients. Clin. Cancer Res. 7, 577-583.
10. De Luca, A., Pignata, S., Casamassimi, A., D'Antonio, A., Gridelli, C., Rossi, A., Cremona, F., Parisi, V., De Matteis, A., Normanno, N. (2000) Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay. Clin. Cancer Res. 6, 1439-1444.
11. Wasserman, L., Dreilinger, A., Easter, D., Wallace, A. (1999) A seminested RT-PCR assay for HER2/neu: initial validation of a new method for the detection of disseminated breast cancer cells. Mol. Diagn. 4, 21-28.
12. Leone, F., Perissinotto, E., Viale, A., Cavalloni, G., Taraglio, S., Capaldi, A., Piacibello, W., Torchio, B., Aglietta, M. (2001) Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction. Bone Marrow Transplant. 27, 517-523.
13. Chan, R., Hardy, W. R., Laing, M. A., Hardy, S. E., Muller, W. J. (2002) The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development. Mol. Cell. Biol. 22, 1073-1078.
14. Alroy, I., Yarden, Y. (1997) The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 410, 83-86.
15. + cord blood cells after ex vivo expansion: evidence for amplification and self-renewal of repopulating stem cells. Blood 93, 3736-3749.
16. Lord, B. I., Molineux, G., Pojda, Z., Souza, L. M., Mennod, J. J., Dexter, T. M. (1991) Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 77, 2154-2159.
17. Lopez, F., Belloc, F., Lacombe, F., Dumain, P., Reiffers, J., Bernard, P., Boisseau, M. R. (1991) Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 12, 42-49.
18. Piacibello, W., Sanavio, F., Garetto, L., Severino, A., Bergandi, D., Ferrario, J., Fagioli, F., Berger, M., Aglietta, M. (1997) Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89, 2644-2653.
19. Gammaitoni, L., Bruno, S., Sanavio, F., Gunetti, M., Kollet, O., Cavalloni, G., Falda, M., Fagioli, F., Lapidot, T., Aglietta, M., Piacibello, W. (2003) Ex-vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp. Hematol. 31, 261-270.
20. Sliwkowski, M. X., Lofgren, J. A., Lewis, G. D., Hotaling, T. E., Fendly, B. M., Fox, J. A. (1999) Nonclinical studies addressing the mechanism of action of Trastuzumab (Herceptin). Semin. Oncol. 26 (4 Suppl. 12), 60-70.
21. Klapper, L. N., Waterman, H., Sela, M., Yarden, Y. (2000) Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. Cancer Res. 60, 3384-3388.
22. Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) Identification of Heregulin, a specific activator of p185ErbB2. Science 256, 1205-1210.
23. Stern, D. F., Kamps, M., P. (1988) EGF-stimulated tyrosine phosphorylaton of p185neu: a potential model for receptor interactions. EMBO J. 7, 995-1001.
24. Brennan, P. J., Kumogai, T., Berezov, A., Murali, R., Greene, M. I. (2000) HER2/Neu: mechanism of dimerization/oligomerization. Oncogene 19, 6093-6103.
25. Lucotti, C., Malabarba, L., Rosti, V., Bergamaschi, G., Danova, M., Invernizzi, R., Pecei, A., Ramajoli, I., Torretta, L., De Amici, M., Salvaneschi, L., Cazzola, M.(2000) Cell cycle distribution of cord blood-derived hematopoietic progenitor cells and their recruitment into S-phase of the cell cycle. Br. J. Haematol. 108, 621-628.
26. Worthylake, R., Wiley, H. (1997) Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2neu. J. Biol. Chem. 272, 8594-8601.
27. King, C. R., Borrello, I., Bellot, F., Comoglio, P., Schlessinger, J. (1988) EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the ErbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J. 7, 1647-1651.
28. Worthylake, R., Opresko, L. K., Wiley, H. (1999) ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors. J. Biol. Chem. 274, 8865-8874.